Snell Kristi 4
4 · YIELD10 BIOSCIENCE, INC. · Filed Feb 14, 2022
Insider Transaction Report
Form 4
Snell Kristi
VP Research & CSO
Transactions
- Award
Common Stock
2022-02-10$3.83/sh+6,733$25,787→ 11,605 total - Award
Stock Option (right to buy)
2022-02-10+22,500→ 22,500 totalExercise: $3.83Exp: 2032-02-10→ Common Stock (22,500 underlying)
Holdings
- 5,210(indirect: By 401(k))
Common Stock
Footnotes (3)
- [F1]The securities awarded are in the form of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 50% of the shares on 8/10/2022 and the remaining 50% on 2/10/2023.
- [F2]Shares acquired as Issuer matching contributions under the Yield10 Bioscience, Inc. 401(k) Plan.
- [F3]These options will vest and become exercisable in equal quarterly installments over 4 years from 2/10/2022, beginning on 5/10/2022 and ending on 2/10/2026.